(Bloomberg Businessweek) -- The man on the operating table is 50, fit and otherwise healthy. Under the care of a different doctor, he might be waking up without a prostate. But today, inside a ...

(RTTNews) - Myriad Genetics (MYGN) and PATHOMIQ have entered into a strategic collaboration for Myriad to exclusively license PATHOMIQ_PRAD, PATHOMIQs AI technology platform for prostate cancer, in ...